Auronext Pharma Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 Hyderabad, Telangana, India Amalgamated
Last Updated:
Access Report
About Auronext Pharma Private Limited

Auronext Pharma Private Limited, a amalgamated private limited company, was established on 02 July 2009 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999TG2009PTC109591. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹255.00 Cr and a paid-up capital of ₹124.98 Cr.

It upholds a compliant status. Employing 293 professional, Its leadership includes Madan Mohan Reddy Mettu (Director), Sapna (Director), Jacob Joseph (Whole-Time Director). Past directors included Vinod Kumar Reddy Aerva, Bodh Raj Sikri, Govindarajan Narayanan. It holds no open charges and ₹36.50 Cr settled loans. Its latest AGM occurred on 19 June 2023, with the balance sheet filed on 31 March 2023. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TG2009PTC109591

  • Registration Number

    109591

  • Incorporation Date

    02 July 2009

  • Authorized Capital

    ₹255.00 Cr

  • Paid-Up Capital

    ₹124.98 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 255.00 Cr
  • Paid Up Capital ₹ 124.98 Cr
  • Company Age 16 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 36.50 Cr
  • Revenue Growth **** 22.87%
  • Profit Growth **** 49.22%
  • Ebitda **** 29.61%
  • Net Worth -1.47%
  • Total Assets -0.04%
Company report

Auronext Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Auronext Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Auronext Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Madan Mohan Reddy Mettu Director 31 Aug 2020 Current
Sapna Director 23 May 2019 Current
Jacob Joseph Whole-Time Director 01 Jul 2021 Current
Venkata Radhakrishna Racharla Company Secretary 15 Apr 2019 Current
Sarath Chandra Reddy Penaka Director 20 Aug 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Nov 2017 Past
Pramod Abcsdd Director 21 Aug 2020 Past
Pramod Abcsdd Director 01 Oct 2015 Past
Pramod Abcsdd Director 31 Aug 2020 Past
Pramod Abcsdd Additional Director 24 Aug 2021 Past
Pramod Abcsdd Director 31 Aug 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Auronext Pharma.

Auronext Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.87% increase. The company also saw a substantial improvement in profitability, with a 49.22% increase in profit. The company's net worth dipped by a decrease of 1.47%.

Auronext Pharma revenue growth over time
Auronext Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 22.87%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.04%
*******
*******
*******
*******
Profit or Loss
*******
 49.22%
*******
*******
*******
*******
Net Worth
*******
 -1.47%
*******
*******
*******
*******
EBITDA
*******
 29.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Auronext Pharma?

In 2023, Auronext Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹365,000,000.00

Charges Breakdown by Lending Institutions
  • Yes Bank Limited : 35.00 Cr
  • Axis Bank Limited : 1.50 Cr
Latest Charge Details
Date Lender Amount Status
21 Jul 2016 Yes Bank Limited ₹35.00 Cr Satisfied
02 Feb 2010 Axis Bank Limited ₹1.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Auronext Pharma?

Auronext Pharma has a workforce of 293 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Auronext Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auronext Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Auronext Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Auronext Pharma Private Limited last Annual general meeting of members was held on 19 Jun 2023 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Auronext Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.

  • Director Appointment

    The activity Ravi Kiran Yellapragada was appointed as a CFO was appointed as a CFO on 01 Jul 2021 & has been associated with this company since 4 years 7 months . was completed.

  • Director Appointment

    The activity Jacob Joseph was appointed as a Whole-time director was appointed as a Whole-time director on 01 Jul 2021 & has been associated with this company since 4 years 7 months . was completed.

  • Charges

    Progress on A charge registered on 21 Jul 2016 via Charge ID 100058300 with Yes Bank Limited was fully satisfied on 08 Feb 2021. was documented.

  • Director Appointment

    The activity Madan Mohan Reddy Mettu was appointed as a Director was appointed as a Director on 31 Aug 2020 & has been associated with this company since 5 years 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Auronext Pharma Private Limited?

The CIN of Auronext Pharma Private Limited is U74999TG2009PTC109591.

Where is Auronext Pharma Private Limited headquartered?

Auronext Pharma Private Limited is headquartered at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.

When was Auronext Pharma Private Limited incorporated?

Auronext Pharma Private Limited was incorporated on 02 July 2009.

Who are the current directors of Auronext Pharma Private Limited?

The current directors of Auronext Pharma Private Limited are

What is the primary industry of Auronext Pharma Private Limited?

The primary industry of Auronext Pharma Private Limited is Manufacturing.

Is Auronext Pharma Private Limited a listed company?

Auronext Pharma Private Limited is unlisted.

What is the capital structure of Auronext Pharma Private Limited?

The authorized capital of Auronext Pharma Private Limited is ₹255.00 Cr, and the paid-up capital is ₹124.98 Cr.

What is the compliance status of Auronext Pharma Private Limited?

The compliance status of Auronext Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available